Immunoadolescence: Neuroimmune development and adolescent behavior

Neuroscience and Biobehavioral Reviews

Volumn 70, Issue , 2016, Pages 288-299

  Brenhouse, Heather C ^a   Schwarz, Jaclyn M ^b  

^a NORTHEASTERN UNIVERSITY   (United States)

^b UNIVERSITY OF DELAWARE   (United States)

Author keywords

Age; Cytokines; Human; Microglia; Rat

Indexed keywords

NEUROTRANSMITTER; CENTRAL DEPRESSANT AGENT;

ADOLESCENT; ADOLESCENT BEHAVIOR; BLOOD BRAIN BARRIER; BRAIN DEVELOPMENT; DEPRESSION; DRUG DEPENDENCE; GLIA CELL; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNOREGULATION; MICROGLIA; NERVE CELL NETWORK; NEUROTRANSMITTER RELEASE; ONSET AGE; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION; ADOLESCENT DEVELOPMENT; BRAIN;

ADOLESCENT; ADOLESCENT BEHAVIOR; ADOLESCENT DEVELOPMENT; BLOOD-BRAIN BARRIER; BRAIN; CENTRAL NERVOUS SYSTEM DEPRESSANTS; HUMANS;

EID: 84973531824     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2016.05.035     Document Type: Review

References (123)

1. Abbott, N.J., Ronnback, L., Hansson, E., Astrocyte-endothelial interactions at the blood-brain barrier. Nat. Rev. Neurosci. 7 (2006), 41–53.
2. Andersen, S.L., Teicher, M.H., Desperately driven and no brakes: developmental stress exposure and subsequent risk for substance abuse. Neurosci. Biobehav. Rev. 33 (2009), 516–524.
3. Andersen, S.L., Trajectories of brain development: point of vulnerability or window of opportunity?. Neurosci. Biobehav. Rev. 27 (2003), 3–18.
4. Ahn, J.J., O'Mahony, J., Moshkova, M., Hanwell, H.E., Singh, H., Zhang, M.A., Marrie, R.A., Bar-Or, A., Sadovnick, D.A., Dunn, S.E., Banwell, B.L., Puberty in females enhances the risk of an outcome of multiple sclerosis in children and the development of central nervous system autoimmunity in mice. Mult. Scler. 21 (2015), 735–748.
5. Arnoux, I., Audinat, E., 2015. Fractalkine signaling and microglia functions in the developing brain. Neural Plast., 2015, 689404.
6. Ashwell, K., Microglia and cell death in the developing mouse cerebellum. Brain Res. Dev. Brain Res. 55 (1990), 219–230.
7. Ashwell, K., The distribution of microglia and cell death in the fetal rat forebrain. Brain Res. Dev. Brain Res. 58 (1991), 1–12.
8. Bale, T.L., Lifetime stress experience: transgenerational epigenetics and germ cell programming. Dialogues Clin. Neurosci. 16 (2014), 297–305.
9. Banks, W.A., Kastin, A.J., Blood to brain transport of interleukin links the immune and central nervous systems. Life Sci. 48 (1991), PL117–121.
10. Banks, W.A., The blood-brain barrier in neuroimmunology: tales of separation and assimilation. Brain Behav. Immun. 44 (2015), 1–8.
11. Barak, B., Feldman, N., Okun, E., Toll-like receptors as developmental tools that regulate neurogenesis during development: an update. Front. Neurosci., 8, 2014, 272.
12. Bartlett, J.A., Schleifer, S.J., Demetrikopoulos, M.K., Delaney, B.R., Shiflett, S.C., Keller, S.E., Immune function in healthy adolescents. Clin. Diagn. Lab. Immunol. 5 (1998), 105–113.
13. Bilbo, S.D., Schwarz, J.M., Early-life programming of later-life brain and behavior: a critical role for the immune system. Front. Behav. Neurosci., 3, 2009, 14.
14. Borre, Y.E., O'Keeffe, G.W., Clarke, G., Stanton, C., Dinan, T.G., Cryan, J.F., Microbiota and neurodevelopmental windows: implications for brain disorders. Trends Mol. Med. 20 (2014), 509–518.
15. Brenhouse, H.C., Andersen, S.L., Developmental trajectories during adolescence in males and females: a cross-species understanding of underlying brain changes. Neurosci. Biobehav. Rev. 35 (2011), 1687–1703.
16. Brenhouse, H.C., Andersen, S.L., Nonsteroidal anti-inflammatory treatment prevents delayed effects of early life stress in rats. Biol. Psychiatry 70 (2011), 434–440.
17. Brenhouse, H.C., Sonntag, K.C., Andersen, S.L., Transient D1 dopamine receptor expression on prefrontal cortex projection neurons: relationship to enhanced motivational salience of drug cues in adolescence. J. Neurosci. 28 (2008), 2375–2382.
18. Barrientos, R.M., Frank, M.G., Watkins, L.R., Maier, S.F., Memory impairments in healthy aging: Role of aging-induced microglial sensitization. Aging Dis. 1 (2010), 212–231.
19. Berczi, I., Neurohormonal host defense in endotoxin shock. Ann. N. Y. Acad. Sci. 840 (1998), 787–802.
20. Bilbo, S.D., Smith, S.H., Schwarz, J.M., A lifespan approach to neuroinflammatory and cognitive disorders: a critical role for glia. J. Neuroimmune. Pharmacol., 2011.
21. Blatteis, C.M., Role of the OVLT in the febrile response to circulating pyrogens. Prog. Brain Res. 91 (1992), 409–412.
22. Blaustein, J.D., Ismail, N., Enduring influence of pubertal stressors on behavioral response to hormones in female mice. Horm. Behav. 64 (2013), 390–398.
23. Blaustein, J.D., Ismail, N., Holder, M.K., 2015. Review: Puberty as a time of remodeling the adult response to ovarian hormones. J. Steroid. Biochem. Mol. Biol, 2015.
24. Brodsky, I.E., Medzhitov, R., Targeting of immune signalling networks by bacterial pathogens. Nat. Cell Biol. 11 (2009), 521–526.
25. Bushong, E.A., Martone, M.E., Ellisman, M.H., Maturation of astrocyte morphology and the establishment of astrocyte domains during postnatal hippocampal development. Int. J. Dev. Neurosci. 22 (2004), 73–86.
26. Cabungcal, J.H., Counotte, D.S., Lewis, E.M., Tejeda, H.A., Piantadosi, P., Pollock, C., Calhoon, G.G., Sullivan, E.M., Presgraves, E., Kil, J., Hong, L.E., Cuenod, M., Do, K.Q., O'Donnell, P., Juvenile antioxidant treatment prevents adult deficits in a developmental model of schizophrenia. Neuron 83 (2014), 1073–1084.
27. Capuron, L., Ravaud, A., Dantzer, R., Early depressive symptoms in cancer patients receiving interleukin 2 and/or interferon alfa-2b therapy. J. Clin. Oncol. 18 (2000), 2143–2151.
28. Canguven, O., Albayrak, S., Do low testosterone levels contribute to the pathogenesis of asthma?. Med. Hypotheses 76 (2011), 585–588.
29. Chan, W.Y., Kohsaka, S., Rezaie, P., The origin and cell lineage of microglia: new concepts. Brain Res. Rev. 53 (2007), 344–354.
30. Clarke, L.E., Barres, B.A., Emerging roles of astrocytes in neural circuit development. Nat. Rev. Neurosci. 14 (2013), 311–321.
31. Crews, F., He, J., Hodge, C., Adolescent cortical development: a critical period of vulnerability for addiction. Pharmacol. Biochem. Behav. 86 (2007), 189–199.
32. Crews, F.T., Vetreno, R.P., Addiction, adolescence, and innate immune gene induction. Front. Psychiatry, 2, 2011, 19.
33. Cunningham, M.G., Bhattacharyya, S., Benes, F.M., Amygdalo-cortical sprouting continues into early adulthood: implications for the development of normal and abnormal function during adolescence. J. Comp. Neurol. 453 (2002), 116–130.
34. Dantzer, R., Bluthe, R.M., Gheusi, G., Cremona, S., Laye, S., Parnet, P., Kelley, K.W., Molecular basis of sickness behavior. Ann. N. Y. Acad. Sci. 856 (1998), 132–138.
35. Dantzer, R., Bluthe, R.M., Laye, S., Bret-Dibat, J.L., Parnet, P., Kelley, K.W., Cytokines and sickness behavior. Ann. N. Y. Acad. Sci. 840 (1998), 586–590.
36. Dennison, U., McKernan, D., Cryan, J., Dinan, T., Schizophrenia patients with a history of childhood trauma have a pro-inflammatory phenotype. Psychol. Med. 42 (2012), 1865–1871.
37. do Prado, C.H., Narahari, T., Holland, F.H., Lee, H.N., Murthy, S.K., Brenhouse, H.C., Effects of early adolescent environmental enrichment on cognitive dysfunction, prefrontal cortex development, and inflammatory cytokines after early life stress. Dev. Psychobiol. 58 (2016), 482–491.
38. Eyo, U.B., Wu, L.J., Bidirectional microglia-neuron communication in the healthy brain. Neural Plas., 2013, 2013, 456857.
39. Ellis, S., Mouihate, A., Pittman, Q.J., Early life immune challenge alters innate immune responses to lipopolysaccharide: implications for host defense as adults. FASEB J. 19 (2005), 1519–1521.
40. Farrar, W.L., Kilian, P.L., Ruff, M.R., Hill, J.M., Pert, C.B., Visualization and characterization of interleukin 1 receptors in brain. J. Immunol. 139 (1987), 459–463.
41. Freeman, M.R., Specification and morphogenesis of astrocytes. Science 330 (2010), 774–778.
42. Fang, P., Schachner, M., Shen, Y.Q., HMGB1 in development and diseases of the central nervous system. Mol. Neurobiol. 45 (2012), 499–506.
43. Fernandez-Lizarbe, S., Montesinos, J., Guerri, C., Ethanol induces TLR4/TLR2 association, triggering an inflammatory response in microglial cells. J. Neurochem. 126 (2013), 261–273.
44. Fillman, S.G., Cloonan, N., Catts, V.S., Miller, L.C., Wong, J., McCrossin, T., Cairns, M., Weickert, C.S., Increased inflammatory markers identified in the dorsolateral prefrontal cortex of individuals with schizophrenia. Mol. Psychiatry 18 (2013), 206–214.
45. Fillman, S.G., Weickert, T.W., Lenroot, R.K., Catts, S.V., Bruggemann, J.M., Catts, V.S., Weickert, C.S., Elevated peripheral cytokines characterize a subgroup of people with schizophrenia displaying poor verbal fluency and reduced Broca's area volume. Mol. Psychiatry, 2015, 10.1038/mp.2015.90.
46. Gadani, S.P., Walsh, J.T., Lukens, J.R., Kipnis, J., Dealing with danger in the CNS: the response of the immune system to injury. Neuron 87 (2015), 47–62.
47. Galic, M.A., Riazi, K., Pittman, Q.J., Cytokines and brain excitability. Front. Neuroendocrinol. 33 (2012), 116–125.
48. Ginhoux, F., Greter, M., Leboeuf, M., Nandi, S., See, P., Gokhan, S., Mehler, M.F., Conway, S.J., Ng, L.G., Stanley, E.R., Samokhvalov, I.M., Merad, M., Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 330 (2010), 841–845.
49. Grassi-Oliveira, R., Holland, F.H., Honeycutt, J.A., Ganguly, P., Brenhouse, H.C., in press Title: Cognitive impairment effects of early life stress in adolescents can be predicted with early biomarkers: Impacts of sex, experience, and cytokines. Psychoneuroendocrinology.
50. Guerra-Silveira, F., Abad-Franch, F., Sex bias in infectious disease epidemiology: patterns and processes. PLoS One, 8, 2013, e62390.
51. Harry, G.J., Kraft, A.D., Microglia in the developing brain: a potential target with lifetime effects. Neurotoxicology 33 (2012), 191–206.
52. Hagan, C.C., Graham, J.M., Wilkinson, P.O., Midgley, N., Suckling, J., Sahakian, B.J., Goodyer, I.M., Neurodevelopment and ages of onset in depressive disorders. Lancet Psychiatry 2 (2015), 1112–1116.
53. Hemmerle, A.M., Ahlbrand, R., Bronson, S.L., Lundgren, K.H., Richtand, N.M., Seroogy, K.B., Modulation of schizophrenia-related genes in the forebrain of adolescent and adult rats exposed to maternal immune activation. Schizophr. Res. 168 (2015), 411–420.
54. Herbert, T.B., Cohen, S., Depression and immunity: a meta-analytic review. Psychol. Bull. 113 (1993), 472–486.
55. Hodes, G.E., Pfau, M.L., Leboeuf, M., Golden, S.A., Christoffel, D.J., Bregman, D., Rebusi, N., Heshmati, M., Aleyasin, H., Warren, B.L., Lebonte, B., Horn, S., Lapidus, K.A., Stelzhammer, V., Wong, E.H., Bahn, S., Krishnan, V., Bolanos-Guzman, C.A., Murrough, J.W., Merad, M., Russo, S.J., Individual differences in the peripheral immune system promote resilience versus susceptibility to social stress. Proc. Natl. Acad. Sci. U.S.A. 111 (2014), 16136–16141.
56. Hutchinson, M.R., Bland, S.T., Johnson, K.W., Rice, K.C., Maier, S.F., Watkins, L.R., Opioid-induced glial activation: mechanisms of activation and implications for opioid analgesia, dependence, and reward. Sci. World J. 7 (2007), 98–111.
57. Karmiloff-Smith, A., Thomas, C.S., The importance of tracing developmental trajectories for clinical child neuropsychology. Reed, J., Warner-Rogers, J., (eds.) Child Neuropsychology: Concepts Theory, and Practice, 2008, Wiley-Blackwell.
58. Karrenbauer, B.D., Muller, C.P., Ho, Y.J., Spanagel, R., Huston, J.P., Schwarting, R.K., Pawlak, C.R., Time-dependent in-vivo effects of interleukin-2 on neurotransmitters in various cortices: relationships with depressive-related and anxiety-like behaviour. J. Neuroimmunol. 237 (2011), 23–32.
59. Keshavan, M.S., Development, disease and degeneration in schizophrenia: a unitary pathophysiological model. J. Psychiatr. Res. 33 (1999), 513–521.
60. Knuesel, I., Chicha, L., Britschgi, M., Schobel, S.A., Bodmer, M., Hellings, J.A., Toovey, S., Prinssen, E.P., Maternal immune activation and abnormal brain development across CNS disorders. Nat. Rev. Neurol. 10 (2014), 643–660.
61. Kriegstein, A., Alvarez-Buylla, A., The glial nature of embryonic and adult neural stem cells. Annu. Rev. Neurosci. 32 (2009), 149–184.
62. Kubota, T., Kushikata, T., Fang, J., Krueger, J.M., Nuclear factor-kappaB inhibitor peptide inhibits spontaneous and interleukin-1beta-induced sleep. Am. J. Physiol. Regul. Integr. Comp. Physiol. 279 (2000), R404–R413.
63. Lapchak, P.A., A role for interleukin-2 in the regulation of striatal dopaminergic function. Neuroreport 3 (1992), 165–168.
64. Levy, O., Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat. Rev. Immunol. 7 (2007), 379–390.
65. Leza, J.C., Garcia-Bueno, B., Bioque, M., Arango, C., Parellada, M., Do, K., O'Donnell, P., Bernardo, M., Inflammation in schizophrenia: a question of balance. Neurosci. Biobehav. Rev. 55 (2015), 612–626.
66. Liu, J., Buisman-Pijlman, F., Hutchinson, M.R., Toll-like receptor 4: innate immune regulator of neuroimmune and neuroendocrine interactions in stress and major depressive disorder. Front. Neurosci., 8, 2014, 309.
67. Liva, S.M., Voskuhl, R.R., Testosterone acts directly on CD4+ T lymphocytes to increase IL-10 production. J. Immunol. 167 (2001), 2060–2067.
68. Male, D., Rezaie, P., Colonisation of the human central nervous system by microglia: the roles of chemokines and vascular adhesion molecules. Castellano, B., Lopez, M.N.-S., (eds.) Progress in Brain Research, 2001, Elsevier, 81–93.
69. Müller, N., Krause, D., Dehning, S., Musil, R., Schennach-Wolff, R., Obermeier, M., Moller, H.J., Klauss, V., Schwarz, M.J., Riedel, M., Celecoxib treatment in an early stage of schizophrenia: results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment. Schizophr. Res. 121 (2010), 118–124.
70. Müller, N., Weidinger, E., Leitner, B., Schwarz, M.J., The role of inflammation in schizophrenia. Front. Neurosci., 9, 2015, 372.
71. Maes, M., Evidence for an immune response in major depression: a review and hypothesis. Prog. Neuropsychopharmacol. Biol. Psychiatry 19 (1995), 11–38.
72. McKimmie, C.S., Graham, G.J., Astrocytes modulate the chemokine network in a pathogen-specific manner. Biochem. Biophys. Res. Commun. 394 (2010), 1006–1011.
73. Michell-Robinson, M.A., Touil, H., Healy, L.M., Owen, D.R., Durafourt, B.A., Bar-Or, A., Antel, J.P., Moore, C.S., Roles of microglia in brain development, tissue maintenance and repair. Brain 138 (2015), 1138–1159.
74. McClory, A.J., Spear, L.P., Effects of ethanol exposure during adolescence or in adulthood on Pavlovian conditioned approach in Sprague-Dawley rats. Alcohol 48 (2014), 755–763.
75. McCutcheon, J.E., Marinelli, M., Age matters. Eur. J. Neurosci. 29 (2009), 997–1014.
76. Miller, G.E., Cole, S.W., Clustering of depression and inflammation in adolescents previously exposed to childhood adversity. Biol. Psychiatry 72 (2012), 34–40.
77. Mills, N.T., Scott, J.G., Wray, N.R., Cohen-Woods, S., Baune, B.T., Research review: the role of cytokines in depression in adolescents: a systematic review. J. Child Psychol. Psychiatry 54 (2013), 816–835.
78. Montesinos, J., Pascual, M., Pla, A., Maldonado, C., Rodriguez-Arias, M., Minarro, J., Guerri, C., TLR4 elimination prevents synaptic and myelin alterations and long-term cognitive dysfunctions in adolescent mice with intermittent ethanol treatment. Brain Behav. Immun. 45 (2015), 233–244.
79. Muller, N., Ackenheil, M., Psychoneuroimmunology and the cytokine action in the CNS: implications for psychiatric disorders. Prog. Neuropsychopharmacol. Biol. Psychiatry 22 (1998), 1–33.
80. Nishijima, T., Piriz, J., Duflot, S., Fernandez, A.M., Gaitan, G., Gomez-Pinedo, U., Verdugo, J.M., Leroy, F., Soya, H., Nunez, A., Torres-Aleman, I., Neuronal activity drives localized blood-brain-barrier transport of serum insulin-like growth factor-I into the CNS. Neuron 67 (2010), 834–846.
81. Northcutt, A.L., Hutchinson, M.R., Wang, X., Baratta, M.V., Hiranita, T., Cochran, T.A., Pomrenze, M.B., Galer, E.L., Kopajtic, T.A., Li, C.M., Amat, J., Larson, G., Cooper, D.C., Huang, Y., O'Neill, C.E., Yin, H., Zahniser, N.R., Katz, J.L., Rice, K.C., Maier, S.F., Bachtell, R.K., Watkins, L.R., DAT isn't all that: cocaine reward and reinforcement require toll-like receptor 4 signaling. Mol. Psychiatry 20 (2015), 1525–1537.
82. Noto, C., Ota, V.K., Gouvea, E.S., Rizzo, L.B., Spindola, L.M., Honda, P.H., Cordeiro, Q., Belangero, S.I., Bressan, R.A., Gadelha, A., Maes, M., Brietzke, E., Effects of risperidone on cytokine profile in drug-naive first-episode psychosis. Int. J. Neuropsychopharmacol., 18, 2015.
83. Ortega, A., Jadeja, V., Zhou, H., 2010. Postnatal development of lipopolysaccharide-induced inflammatory response in the brain. Inflamm. Res., 2010.
84. Perry, V.H., Hume, D.A., Gordon, S., Immunohistochemical localization of macrophages and microglia in the adult and developing mouse brain. Neuroscience 15 (1985), 313–326.
85. Perry, V.H., Newman, T.A., Cunningham, C., The impact of systemic infection on the progression of neurodegenerative disease. Nat. Rev. Neurosci. 4 (2003), 103–112.
86. Rankin, J.S., Zalcman, S.S., Zhu, Y., Siegel, A., Short- and long-term effects of interleukin-2 treatment on the sensitivity of periadolescent female mice to interleukin-2 and dopamine uptake inhibitor. PLoS One, 8, 2013, e64473.
87. Rezaie, P., Patel, K., Male, D.K., Microglia in the human fetal spinal cord—patterns of distribution, morphology and phenotype. Brain Res. Dev. Brain Res. 115 (1999), 71–81.
88. Rivest, S., Regulation of innate immune responses in the brain. Nat. Rev. Immunol. 9 (2009), 429–439.
89. Riis, J.L., Out, D., Dorn, L.D., Beal, S.J., Denson, L.A., Pabst, S., Jaedicke, K., Granger, D.A., Salivary cytokines in healthy adolescent girls: intercorrelations, stability, and associations with serum cytokines, age, and pubertal stage. Dev. Psychobiol. 56 (2014), 797–811.
90. Selemon, L.D., A role for synaptic plasticity in the adolescent development of executive function. Transl. Psychiatry, 3, 2013, e238.
91. Schulz, K.M., Molenda-Figueira, H.A., Sisk, C.L., Back to the future: the organizational-activational hypothesis adapted to puberty and adolescence. Horm. Behav. 55 (2009), 597–604.
92. Schwandt, M.L., Lindell, S.G., Chen, S., Higley, J.D., Suomi, S.J., Heilig, M., Barr, C.S., Alcohol response and consumption in adolescent rhesus macaques: life history and genetic influences. Alcohol 44 (2010), 67–80.
93. Schwarz, J.M., Bilbo, S.D., The Immune System and the Developing Brain. 2011, Morgan & Claypool Life Sciences.
94. Schwarz, J.M., Bilbo, S.D., Adolescent morphine exposure affects long-term microglial function and later-life relapse liability in a model of addiction. J. Neurosci. 33 (2013), 961–971.
95. Schwarz, J.M., Hutchinson, M.R., Bilbo, S.D., Early-life experience decreases drug-induced reinstatement of morphine CPP in adulthood via microglial-specific epigenetic programming of anti-inflammatory IL-10 expression. J. Neurosci. 31 (2011), 17835–17847.
96. Selemon, L.D., Zecevic, N., Schizophrenia: a tale of two critical periods for prefrontal cortical development. Transl. Psychiatry, 5, 2015, e623.
97. Shah, S., Hormonal link to autoimmune allergies. ISRN Allergy, 2012, 910437.
98. Squarzoni, P., Thion, M.S., Garel, S., Neuronal and microglial regulators of cortical wiring: usual and novel guideposts. Front. Neurosci., 9, 2015, 248.
99. Stipursky, J., Romao, L., Tortelli, V., Neto, V.M., Gomes, F.C., Neuron-glia signaling: implications for astrocyte differentiation and synapse formation. Life Sci. 89 (2011), 524–531.
100. Shames, R.S., Gender differences in the development and function of the immune system. J. Adolesc. Health 30 (2002), 59–70.
101. Sisk, C.L., Foster, D.L., The neural basis of puberty and adolescence. Nat. Neurosci. 7 (2004), 1040–1047.
102. Smith, C.P., Dunger, D.B., Williams, A.J., Taylor, A.M., Perry, L.A., Gale, E.A., Preece, M.A., Savage, M.O., Relationship between insulin, insulin-like growth factor I, and dehydroepiandrosterone sulfate concentrations during childhood, puberty, and adult life. J. Clin. Endocrinol. Metab. 68 (1989), 932–937.
103. Smith, A.R., Steinberg, L., Strang, N., Chein, J., Age differences in the impact of peers on adolescents’ and adults’ neural response to reward. Dev. Cogn. Neurosci. 11 (2015), 75–82.
104. Sonuga-Barke, E.J., Cortese, S., Fairchild, G., Stringaris, A., Annual Research Review: transdiagnostic neuroscience of child and adolescent mental disorders—differentiating decision making in attention-deficit/hyperactivity disorder, conduct disorder, depression, and anxiety. J. Child Psychol. Psychiatry 57 (2016), 321–349.
105. Spear, L., The adolescent brain and age-related behavioral manifestations. Neurosci. Biobehav. Rev. 24 (2000), 417–463.
106. Spear, L., Modeling adolescent development and alcohol use in animals. Alcohol Res. Health 24 (2000), 115–123.
107. Stanis, J.J., Andersen, S.L., Reducing substance use during adolescence: a translational framework for prevention. Psychopharmacology (Berl) 231 (2014), 1437–1453.
108. Sui, Y.T., Bullock, K.M., Erickson, M.A., Zhang, J., Banks, W.A., Alpha synuclein is transported into and out of the brain by the blood-brain barrier. Peptides 62 (2014), 197–202.
109. Svensson, J., Diez, M., Engel, J., Wass, C., Tivesten, A., Jansson, J.O., Isaksson, O., Archer, T., Hokfelt, T., Ohlsson, C., Endocrine, liver-derived IGF-I is of importance for spatial learning and memory in old mice. J. Endocrinol. 189 (2006), 617–627.
110. Tarbox, S.I., Addington, J., Cadenhead, K.S., Cannon, T.D., Cornblatt, B.A., Perkins, D.O., Seidman, L.J., Tsuang, M.T., Walker, E.F., Heinssen, R., McGlashan, T.H., Woods, S.W., Premorbid functional development and conversion to psychosis in clinical high-risk youths. Dev. Psychopathol. 25 (2013), 1171–1186.
111. Tollerud, D.J., Ildstad, S.T., Brown, L.M., Clark, J.W., Blattner, W.A., Mann, D.L., Neuland, C.Y., Pankiw-Trost, L., Hoover, R.N., T-cell subsets in healthy teenagers: transition to the adult phenotype. Clin. Immunol. Immunopathol. 56 (1990), 88–96.
112. Town, T., Nikolic, V., Tan, J., The microglial “activation” continuum: from innate to adaptive responses. J. Neuroinflamm., 2, 2005, 24.
113. Tremblay, M.E., Lowery, R.L., Majewska, A.K., Microglial interactions with synapses are modulated by visual experience. PLoS Biol., 8, 2010, e1000527.
114. Tseng, K.Y., O'Donnell, P., Dopamine modulation of prefrontal cortical interneurons changes during adolescence. Cereb. Cortex 17 (2007), 1235–1240.
115. Vetreno, R.P., Crews, F.T., Adolescent binge drinking increases expression of the danger signal receptor agonist HMGB1 and Toll-like receptors in the adult prefrontal cortex. Neuroscience 226 (2012), 475–488.
116. Vitiello, B., Recent developments and strategies in pediatric pharmacology research in the USA. Child Adolesc. Psychiatry Ment. Health, 2, 2008, 36.
117. Vitkovic, L., Bockaert, J., Jacque, C., “Inflammatory” cytokines: neuromodulators in normal brain?. J. Neurochem. 74 (2000), 457–471.
118. Vitkovic, L., Konsman, J.P., Bockaert, J., Dantzer, R., Homburger, V., Jacque, C., Cytokine signals propagate through the brain. Mol. Psychiatry 5 (2000), 604–615.
119. Wieck, A., Andersen, S.L., Brenhouse, H.C., Evidence for a neuroinflammatory mechanism in delayed effects of early life adversity in rats: relationship to cortical NMDA receptor expression. Brain Behav. Immun. 28 (2013), 218–226.
120. Wu, Y., Dissing-Olesen, L., MacVicar, B.A., Stevens, B., Microglia: Dynamic Mediators of Synapse Development and Plasticity. Trends Immun. 36 (2015), 605–613.
121. Yan, H., Mitschelen, M., Bixler, G.V., Brucklacher, R.M., Farley, J.A., Han, S., Freeman, W.M., Sonntag, W.E., Circulating IGF1 regulates hippocampal IGF1 levels and brain gene expression during adolescence. J. Endocrinol. 211 (2011), 27–37.
122. Yarlagadda, A., Alfson, E., Clayton, A.H., The blood brain barrier and the role of cytokines in neuropsychiatry. Psychiatry (Edgmont.) 6 (2009), 18–22.
123. Zhang, Y., Barres, B.A., Astrocyte heterogeneity: an underappreciated topic in neurobiology. Curr Opin Neurobiol. 20 (2010), 588–594.